I-Mab to Participate at the Piper Sandler Healthcare Conference
I-Mab (NASDAQ: IMAB), a U.S.-based global biotech company focused on cancer immunotherapies, has announced its participation in the Piper Sandler 36th Annual Healthcare Conference in New York from December 3-5, 2024. The company's management team will deliver a presentation on December 4 at 4:30 p.m. ET. Key participants include CEO Sean Fu, CMO Phillip Dennis, CFO Joseph Skelton, and Senior Director of IR Tyler Ehler. The event will feature one-on-one and small group meetings during December 3-4. A webcast of the presentation will be accessible through the company's IR website.
I-Mab (NASDAQ: IMAB), un'azienda biotecnologica globale con sede negli Stati Uniti, focalizzata sulle immunoterapie per il cancro, ha annunciato la sua partecipazione alla 36ª Conferenza Sanitaria Annuale di Piper Sandler a New York dal 3 al 5 dicembre 2024. Il team di gestione dell'azienda presenterà il 4 dicembre alle 16:30 ET. I partecipanti chiave includono il CEO Sean Fu, il CMO Phillip Dennis, il CFO Joseph Skelton e il Direttore Senior delle Relazioni con gli Investitori Tyler Ehler. L'evento offrirà incontri individuali e riunioni in piccoli gruppi nei giorni 3 e 4 dicembre. Una trasmissione in diretta della presentazione sarà disponibile sul sito web delle relazioni con gli investitori dell'azienda.
I-Mab (NASDAQ: IMAB), una empresa biotecnológica global con sede en EE. UU. centrada en inmunoterapias contra el cáncer, ha anunciado su participación en la 36ª Conferencia Anual de Salud de Piper Sandler en Nueva York del 3 al 5 de diciembre de 2024. El equipo de gestión de la empresa realizará una presentación el 4 de diciembre a las 4:30 p.m. ET. Los participantes clave incluyen al CEO Sean Fu, CMO Phillip Dennis, CFO Joseph Skelton y Director Senior de IR Tyler Ehler. El evento contará con reuniones uno a uno y en grupos pequeños durante el 3 y 4 de diciembre. Una transmisión web de la presentación estará disponible a través del sitio web de IR de la empresa.
I-Mab (NASDAQ: IMAB)는 미국에 본사를 둔 글로벌 생명공학 회사로, 암 면역 치료에 집중하고 있으며, 2024년 12월 3일부터 5일까지 뉴욕에서 열리는 파이퍼 샌들러 제36회 연례 보건 회의에 참가한다고 발표했습니다. 회사의 경영팀은 12월 4일 오후 4시 30분 ET에 발표를 진행할 예정입니다. 주요 참가자로는 CEO Sean Fu, CMO Phillip Dennis, CFO Joseph Skelton, 그리고 IR 수석 이사 Tyler Ehler가 있습니다. 이번 행사에서는 12월 3일과 4일에 일대일 및 소그룹 회의가 진행됩니다. 발표의 웹캐스트는 회사 IR 웹사이트를 통해 접근할 수 있습니다.
I-Mab (NASDAQ: IMAB), une entreprise biopharmaceutique mondiale basée aux États-Unis, spécialisée dans les immunothérapies contre le cancer, a annoncé sa participation à la 36e Conférence Annuelle de Santé de Piper Sandler à New York du 3 au 5 décembre 2024. L'équipe de direction de l'entreprise fera une présentation le 4 décembre à 16h30 ET. Parmi les participants clés, on trouve le PDG Sean Fu, le CMO Phillip Dennis, le CFO Joseph Skelton et le Directeur Senior des Relations Investisseurs Tyler Ehler. L'événement proposera des réunions en tête-à-tête et en petits groupes les 3 et 4 décembre. Un webcast de la présentation sera disponible sur le site des relations investisseurs de l'entreprise.
I-Mab (NASDAQ: IMAB), ein globales Biotechnologieunternehmen mit Sitz in den USA, das sich auf Krebsimmuntherapien spezialisiert hat, hat seine Teilnahme an der 36. jährlichen Gesundheitskonferenz von Piper Sandler in New York vom 3. bis 5. Dezember 2024 angekündigt. Das Management-Team des Unternehmens wird am 4. Dezember um 16:30 Uhr ET eine Präsentation halten. Zu den Schlüsselteilnehmern gehören CEO Sean Fu, CMO Phillip Dennis, CFO Joseph Skelton und Senior Director of IR Tyler Ehler. Die Veranstaltung beinhaltet Einzelgespräche und kleine Gruppenmeetings am 3. und 4. Dezember. Ein Webcast der Präsentation wird über die IR-Website des Unternehmens zugänglich sein.
- None.
- None.
The 36th Annual Healthcare Conference will be held in
Piper Sandler 36th Annual Healthcare Conference Presentation Details
Presentation Time | Wednesday, December 4 at 4:30 p.m. ET |
Presenters | Sean Fu, PhD, MBA, Chief Executive Officer Phillip Dennis, MD, PhD, Chief Medical Officer |
Webcast link | |
Meetings | One-on-one and small group meetings: December 3 – 4, 2024 |
Management | Sean Fu, PhD, MBA, Chief Executive Officer Joseph Skelton, Chief Financial Officer Phillip Dennis, MD, PhD, Chief Medical Officer Tyler Ehler, Senior Director, Investor Relations |
The webcast will also be available under "Event Calendar" on I-Mab's IR website
at https://ir.i-mabbiopharma.com/
For more information, please contact your Piper Sandler representative.
About I-Mab
I-Mab (NASDAQ: IMAB) is a US-based, global biotech company, exclusively focused on the development of highly differentiated immunotherapies for the treatment of cancer. I-Mab has established operations in
For more information, please contact:
Tyler Ehler
Senior Director, Investor Relations
IR@imabbio.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/i-mab-to-participate-at-the-piper-sandler-healthcare-conference-302312202.html
SOURCE I-Mab Biopharma
FAQ
When is I-Mab (IMAB) presenting at the Piper Sandler Healthcare Conference 2024?
Who are the key presenters from I-Mab (IMAB) at the Piper Sandler Conference 2024?
Where can I watch I-Mab's (IMAB) Piper Sandler Conference presentation?
What type of meetings is I-Mab (IMAB) conducting at the Piper Sandler Conference 2024?
